Cadrenal Therapeutics, Inc. funding
Cadrenal Therapeutics, Inc., a biotechnology company based in Ponte Vedra, FL (founded 2022), filed a Form D with the SEC on July 15, 2026 and reported $8.8M raised. It filed 3 new offerings in this period, totaling $21.2M.
Amount raised$8.8M
Offering size$8.8M
Filed with the SECJuly 15, 2026
First saleJune 30, 2026
IndustryBiotechnology
SecuritiesOptions or warrants, Security to be acquired on exercise
LocationPonte Vedra, FL
Founded2022
Entity typeCorporation
Investors so far1
Minimum investment—
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Jul 15
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| July 15, 2026 | $8.8M | $8.8M | Options or warrants, Security to be acquired on exercise |
| April 6, 2026 | $7.9M | $7.9M | Options or warrants, Security to be acquired on exercise |
| December 31, 2025 | $4.4M | $4.4M | Options or warrants, Security to be acquired on exercise |
Other health care rounds in Florida
Curadel Surgical Innovations, Inc.$49.8M · Oct 13BiotechnologyBioStem Technologies, Inc.$3M · Oct 9BiotechnologyModern Medical Holdings, Inc$3M · Sep 25Hospitals and PhysiciansAscoltare Holdings LLC$1.7M · Oct 23BiotechnologyHCW Biologics Inc.$1.5M · Oct 8BiotechnologyImmorta Bio, Inc.$613K · Oct 16BiotechnologyCoast Medical Innovations, LLC$550K · Oct 8Other Health CareGOA Therapeutics Corp$300K · Nov 5Pharmaceuticals